Title: Marx IE, et al. Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement. ACS Med Chem Lett. 2016 Sep 21;7(12):1062-1067.
1144477-35-9 | TM-N1324 | AA01EOK1 | MFCD12213621
1883727-34-1 | AMG-176 | AA01EONW | MFCD31747169
1952336-78-5 | 5-[3-(4-hydroxybenzoyl)-1H-indol-1-yl]-2-pentanone | AA01EOXN
2222132-40-1 | guanylyl-(3'→5')-3'-guanylicacid,cyclicnucleotide,disodiumsalt | AA01EP7W | MFCD28580125
853400-67-6 | N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-glycine,pentapotassiumsalt | AA01EPGG
126062-19-9 | 7-Amino-4-chloro-3-propoxy-1H-isochromen-1-one | AA01EPLR | MFCD22378306
136560-76-4 | N-[(9Z)-1-oxo-9-octadecen-1-yl]-L-leucine | AA01EPSC
1400742-33-7 | 1-(cyclohexylmethyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide | AA01EQ10
1443-50-1 | N,N-dimethyl-N'-phenyl-N'-[1-(2-phenylethyl)-4-piperidinyl]-urea | AA01EQ7Z
2101958-02-3 | SquarunkinA | AA01EQD4